Cubist Systematic Strategies, LLC Gossamer Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $112,066 - $211,525	140,083 New	140,083 $165,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $133,783 - $208,866	-136,514 Reduced 54.76%	112,798 $135,000
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $82,476 - $250,865	85,913 Added 52.58%	249,312 $314,000
Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $606,202 - $4.48 Million	-348,392 Reduced 68.07%	163,399 $354,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $3.22 Million - $6.65 Million	447,095 Added 691.07%	511,791 $6.13 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $188,449 - $314,713	-31,566 Reduced 32.79%	64,696 $542,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $331,725 - $490,906	39,304 Added 69.01%	96,262 $836,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $182,767 - $254,104	-18,060 Reduced 24.07%	56,958 $644,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $441,684 - $805,998	60,922 Added 432.19%	75,018 $943,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $231,664 - $282,340	-28,958 Reduced 67.26%	14,096 $114,000
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $235,504 - $298,541	27,289 Added 173.1%	43,054 $398,000
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $273,335 - $447,545	-32,932 Reduced 67.63%	15,765 $152,000
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $108,581 - $141,732	9,609 Added 24.58%	48,697 $604,000
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $372,117 - $624,626	39,088 New	39,088 $508,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.